D2G Oncology is Drug Discovery in United States that focus on developer business. Founded in 2018. They cover business area such as developer, drug, genotype, precision cancer therapeutic, quantitative and multiplexed functional cancer genomic, user, well cancer therapeutic.
2018
( 6 years old in 2024 )
Developer
-
320 Logue Avenue
Suite 132
Mountain View, CA 94043
United States
Private
developerdruggenotypeprecision cancer therapeuticquantitative and multiplexed functional cancer genomicuserwell cancer therapeutic
* We use standard office opening hours in near D2G Oncology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
D2G Oncology is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), D2G Oncology business is focusing on Developer.
D2G Oncology headquarter office and corporate office address is located in 320 Logue Avenue Suite 132 Mountain View, CA 94043 United States.
D2G Oncology was founded in United States.
In 2024, D2G Oncology is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with D2G Oncology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
